At Mediomics, we strive to help scientists and researchers discover new drugs. We are an innovative life sciences company specializing in homogeneous assay kits. Our goal is to make the lives of scientists and researchers easier. Our focus is quick and easy assay kits, high affinity binding reagents, and biosensors for detecting biologically and therapeutically important macromolecules, biomarkers, and pathogens. These kits are valuable resources for scientists in the pharmaceutical, biopharmaceutical, and biotechnology industries, as well as university, hospital, and national laboratory researchers. Our platform Bridge-It, FRET-PINCER, and TRF-PINCER technologies have already been adapted for the detection of a range of important macromolecules, including cAMP, tryptophan, S-adenosyl methionine, PDE, biotin, insulin, C-peptide, albumin, C-reactive protein (hCRP), IgG, IgM, E. coli, and others.
Looking for a particular Mediomics, LLC employee's phone or email?
The Mediomics, LLC annual revenue was $11 million in 2026.
Yie-Hwa Chang is the Founder of Mediomics, LLC.
4 people are employed at Mediomics, LLC.
Mediomics, LLC is based in St. Louis, Missouri.
The NAICS codes for Mediomics, LLC are [541714, 541, 5417, 54, 54171].
The SIC codes for Mediomics, LLC are [87, 873].